Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
J Hazard Mater ; 2013 Jan 05.
Article in English | MEDLINE | ID: mdl-23340404

ABSTRACT

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

2.
Pancreatology ; 7(2-3): 187-93, 2007.
Article in English | MEDLINE | ID: mdl-17592233

ABSTRACT

BACKGROUND/AIMS: Obesity and diabetes mellitus (DM) are associated with pancreatic cancer. The present study evaluated tumor staging and resection of pancreatic adenocarcinoma (PaC) according to previous Body Mass Index (BMI), BMI on admission and DM duration. METHODS: A retrospective analysis of 151 consecutive patients with PaC was performed: 73 were evaluated according to BMI preceding tumor-related weight loss and BMI on admission; 118 according to DM diagnosis; and 38 were assessed according to DM duration (less than 1 year [recent-onset] versus more than 2 years [long-standing]). RESULTS: There was no difference in the prevalence of tumor stage III or IV between previously normal weight and overweight/obese patients (56 vs. 42%, NS). Tumor resection rate was higher in previously obese than in previously lean patients (58 vs. 24%, p < 0.05). Tumor staging and resection were similar between normal weight and overweight/obese patients considering BMI on admission and diagnosis of DM. Weight loss was more pronounced in diabetic than in non-diabetic patients (21.7 vs. 13.3%, p < 0.01). Tumor staging and resection were similar between recent-onset and long-standing diabetic patients. CONCLUSION: Tumor resection rate was lower in previously normal weight patients. Diabetics lost more weight than non-diabetic patients. Neither BMI on admission nor the presence of DM nor DM duration influenced tumor staging or resection in PaC patients.


Subject(s)
Adenocarcinoma/pathology , Body Mass Index , Diabetes Complications/pathology , Diabetes Mellitus/pathology , Pancreatic Neoplasms/pathology , Adenocarcinoma/complications , Adenocarcinoma/surgery , Female , Hospitals, University , Humans , Male , Middle Aged , Neoplasm Staging , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/surgery , Time Factors
3.
J Appl Microbiol ; 101(6): 1224-31, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17105552

ABSTRACT

AIMS: To determine the association between rainfall rate and occurrence of enterovirus infection related to contamination of drinking water. METHODS AND RESULTS: One fatality case and three cases of severe illness were observed during the enterovirus epidemic in a village in southern Taiwan from 16 September to 3 October 1998. Groundwater samples were collected from the public well in the village after heavy rainfall to test for enterovirus using the reverse transcription-polymerase chain reaction (RT-PCR) assay. The RT-PCR assay detected the enterovirus in the groundwater sample collected on 26 September 1998. The logistic regression model also revealed a statistically significant association between the rainfall rate and the observation of cases of enterovirus infection. CONCLUSIONS: According to the fitted logistic regression model, the probability of detecting cases of enterovirus infection was greater than 50% at rainfall rates >31 mm h(-1). The higher the rainfall rate, the higher the probability of enterovirus epidemic. SIGNIFICANCE AND IMPACT OF THE STUDY: Contamination of drinking water by the enterovirus may lead to epidemics that cause deaths and severe illness, and such contamination may be caused by heavy rainfall. The major finding in this study is that the enterovirus could be flushed to groundwater in an unconfined aquifer after a heavy rainfall. This work allows for a warning level so that an action can be taken to minimize future outbreaks and so protect public health.


Subject(s)
Developing Countries , Enterovirus Infections/epidemiology , Public Health , Rain , Water Pollution/adverse effects , Water Supply/analysis , Disease Outbreaks , Enterovirus/genetics , Genes, Viral , Humans , Logistic Models , Reverse Transcriptase Polymerase Chain Reaction , Taiwan/epidemiology
4.
J Clin Endocrinol Metab ; 87(8): 3578-82, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12161478

ABSTRACT

Bromocriptine (BRC) and other dopamine agonist drugs are the first-choice treatment for prolactinomas. However, the major disadvantage is the need for prolonged therapy. We retrospectively studied 131 patients [62 microprolactinoma (MIC), 69 macroprolactinoma (MAC)], who achieved serum prolactin (PRL) normalization during BRC use. Twenty-seven percent of them (31% MIC and 69% MAC) underwent previous surgery. Twenty-seven patients (20.6%: 25.8% MIC and 15.9% MAC) persisted with normoprolactinemia after a median time of 44 months of BRC withdrawal. The median time of BRC use was 47 months. There were no statistically significant differences regarding age, gender, BRC initial dose, length of BRC use, tumor size, pregnancy during treatment, previous surgery, or radiotherapy among patients who persisted with normoprolactinemia and those who did not, using both univariate and multivariate analysis. BRC-induced prolactinoma cell alterations are highly controversial; and so, whether the mechanism of PRL normalization after BRC withdrawal is related to BRC use or whether it is attributable to natural history is a matter for debate. A periodic assessment of PRL levels during BRC (and other dopamine-agonist drugs) withdrawal is recommended to avoid the unnecessary maintenance of therapy in a subset of patients with prolactinomas.


Subject(s)
Bromocriptine/administration & dosage , Hormone Antagonists/administration & dosage , Pituitary Neoplasms/drug therapy , Prolactin/blood , Prolactinoma/drug therapy , Adolescent , Adult , Aged , Child , Cohort Studies , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Pituitary Neoplasms/pathology , Pregnancy , Prolactinoma/pathology , Retrospective Studies , Treatment Outcome
6.
J Clin Apher ; 5(1): 7-11, 1989.
Article in English | MEDLINE | ID: mdl-2777739

ABSTRACT

There is evidence that leukocyte contaminating red blood cells and platelet concentrates are responsible for refractoriness to platelet transfusions. The efficacy of a cotton-wool filter to remove leukocytes from red blood cells has been documented previously. The present study was designed to evaluate whether the cotton-wool filters can effectively remove leukocytes from platelet concentrates. Sixty pools of random-donor platelets and single-donor plateletpheresis products were filtered through a cotton-wool filter. The efficacy of filtration was determined by measuring the absolute numbers of leukocytes and platelets and subpopulations of mononuclear cells. The average platelet loss was 8% per pool of random platelets and 10% per plateletpheresis product. The average leukocyte removal was 99% from a pool of random platelets and plateletpheresis concentrates collected by CS-3000 and 90% from plateletpheresis concentrates harvested by single-stage COBE/IBM-2997. The filtration removed 100% of granulocytes, 95% of monocytes, 90% of B-lymphocytes, and 85% of T-lymphocytes. We conclude that filtration through a cotton-wool filter is an efficient and cost-effective method for preparation of leukocyte-poor platelets.


Subject(s)
Blood Component Removal/methods , Plateletpheresis/methods , Filtration/instrumentation , Humans , Leukocyte Count , Microscopy, Electron , Platelet Aggregation , Platelet Count
SELECTION OF CITATIONS
SEARCH DETAIL
...